The causes of slowed or missed hospital cash flow are structural, and most of them trace back to the same set of breakdowns happening at predictable points across the claims lifecycle.
Hospitals lost more than $48 billion in net revenue leakage in 2025, a 25% increase from the year before. The problem isn’t that revenue cycle teams aren’t working hard enough. It’s that they’re often working the wrong things at the wrong time or not seeing the problem until it’s too late to fix.
Here are seven places where that breakdown impacts hospital cash flow the most.
1. Authorization gaps that don’t surface until after discharge
Prior authorization failures are still the leading driver of clinical denials. Clinical denial rates hit 2.6% in 2025, up from 2.4% in 2024, with lack of prior authorization and medical necessity accounting for nearly all that increase. When authorization problems aren’t identified until a claim hits the payer, the clinical team is already gone, the window for concurrent intervention has closed, and the burden shifts to the back end, where recovery is harder and more expensive.
2. Medical necessity documentation that doesn’t anticipate payer logic
Payers aren’t always adjudicating claims against what’s clinically reasonable. They’re running them against proprietary criteria like InterQual, MCG, or their own internal thresholds, and the gap between those criteria and what’s documented in the chart is where medical necessity denials live. For inpatient claims in particular, the documentation has to tell a specific story. When it doesn’t, the result is either a denial or a DRG downgrade. Neither shows up as a problem during the encounter; both become one afterward.
3. DRG assignment left unvalidated before submission
DRG downgrades are among the most financially impactful adverse payment outcomes hospitals face, and among the least visible. Unlike a clinical denial, a DRG downgrade doesn’t always arrive as a rejection. A payer may simply pay at a lower DRG, and without the infrastructure to catch the discrepancy, the underpayment gets posted and moved on from. RevProtect flags DRG downgrade risk during the encounter, before the claim is finalized, which is the only point in the lifecycle where correcting it doesn’t cost additional labor to recover.
4. A flat denial worklist with no prioritization logic
Not all denied claims have the same recovery probability. Some have a high overturn likelihood and a large dollar value. Some are lost causes. When a revenue cycle team works a flat queue, first in, first out, or sorted by dollar value alone, they’re spending equivalent effort on accounts with wildly different return potential. The result is slowed hospital cashflow, wasted touches, missed filing windows in high-probability cases, and a write-off rate higher than it needs to be. RevProtect scores denials by overturn probability, so teams are working the accounts most worth fighting, not just the ones that arrived first.
5. Payer follow-up windows that close without action
Aging claims without a payer response are a quiet cash flow problem. When a claim sits past its expected response window without follow-up, the practical consequence is either a missed timely filing deadline or a lapsed appeal right, both of which turn a potentially recoverable account into a write-off. The issue is that most teams don’t have visibility into which accounts are approaching those windows until it’s already a problem. Proactive denial flagging, before the deadline passes, not after, is the difference between a recoverable denial and a permanent one.
6. Post-payment takebacks that go undetected
Recoupments and post-payment adjustments occur well after a claim is marked as resolved. Medicare Advantage plans have been particularly aggressive, with the average denied amount rising 22.4% year over year and hospital reimbursement from MA plans falling 8.8% on a cost basis between 2019 and 2024 (covered in detail in Sift’s Denials Insights Report). Many of these adjustments arrive as contractual adjustments in the remittance, processed automatically, and never reviewed. They don’t trigger a denial workflow. They don’t show up in denial rate metrics. They’re just gone. Revenue integrity programs that don’t extend past the initial adjudication decision are leaving real money on the table and slowing hospital cash flow.
7. No systematic view of root cause across the lifecycle
The most expensive claims lifecycle gap isn’t any individual failure point, it’s the absence of a connected view across all of them. When denials are managed in silos (CDI working documentation, coders working DRG, billing working appeals, A/R working follow-up), no one has visibility into the patterns that are generating the problem upstream. A clinical documentation issue that produces fifty denials over six months looks like fifty separate problems. With root cause visibility across the lifecycle, it looks like what it is, one fixable problem.
Proactive Denials Management to Accelerate Hospital Cash Flow
Hospital revenue cycle teams that are only managing denials reactively are catching problems at the most expensive point in the lifecycle. The lifecycle gaps above are largely preventable, but only if they’re visible before the claim leaves the building. See how Sift leverages historical payments data, AI-mined payer behavior trends and advanced predictive models to equip revenue cycle teams to prevent denials and optimize recovery efforts.
